Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Ultrasound Med ; 40(12): 2675-2683, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33665892

RESUMEN

PURPOSE: Left ventricular assist device (LVAD) support is associated with peripheral vascular abnormalities beyond those associated with heart failure (HF). These abnormalities are associated with persistent functional impairments that adversely impact quality of life (QoL). Methods for measuring peripheral vascular function in this population are needed. METHODS: This pilot study investigated the use of contrast-enhanced ultrasound (CEUS) using standardized protocols to estimate changes in peripheral (quadriceps) muscle perfusion among patients with HF (INTERMACS profile 3) undergoing LVAD implantation (n = 7). Patients were then stratified by those who did ("responders", n = 4) and did not ("nonresponders", n = 3) report QoL improvement with LVAD support. RESULTS: Serial measurements obtained preoperatively and 3 months following LVAD implantation showed no significant change (P > .23) in muscle perfusion by all CEUS-based measures at rest or with an exercise stimulus for the overall population. Responders exhibited improved muscle perfusion at rest (P = .043) and decreased time to peak contrast enhancement (P = .010) at 3 months compared with baseline, suggesting improved delivery of blood to the extremities post-LVAD. Nonresponders showed unchanged resting muscle perfusion (P > .99), time to peak contrast enhancement (P = .59), and response to exercise stimulus (P > .99) following LVAD therapy. CONCLUSION: Our findings suggest that CEUS evaluation is a promising noninvasive, quantitative modality for real-time assessment of peripheral vasculature and muscle perfusion as an indication of treatment response in LVAD recipients and that this modality may capture perfusion measures important to QoL following LVAD implantation.


Asunto(s)
Insuficiencia Cardíaca , Corazón Auxiliar , Insuficiencia Cardíaca/diagnóstico por imagen , Insuficiencia Cardíaca/terapia , Humanos , Músculos , Perfusión , Proyectos Piloto , Calidad de Vida
2.
J Card Surg ; 31(2): 117-9, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26635205

RESUMEN

We experienced a case with the left atrium almost completely filled with a thrombus after orthotopic heart transplantation while the patient was supported on extracorporeal membrane oxygenation for primary graft failure. The patient had recurrent thrombosis even after successful surgical thrombectomy and appropriate anticoagulation. The cardiac thrombosis resolved only after starting plasmapheresis.


Asunto(s)
Cardiopatías/terapia , Trasplante de Corazón , Isquemia Miocárdica/cirugía , Plasmaféresis , Complicaciones Posoperatorias/terapia , Trombosis/terapia , Anticoagulantes/uso terapéutico , Ecocardiografía Transesofágica , Oxigenación por Membrana Extracorpórea , Cardiopatías/diagnóstico por imagen , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/diagnóstico por imagen , Periodo Posoperatorio , Recurrencia , Trombectomía , Trombosis/diagnóstico por imagen , Resultado del Tratamiento
4.
J Am Soc Echocardiogr ; 35(5): 460-468, 2022 05.
Artículo en Inglés | MEDLINE | ID: mdl-34954049

RESUMEN

BACKGROUND: Accurate expected effective orifice area (EOA) values for balloon-expandable (BE) transcatheter heart valves (THV) are crucial for preventing patient-prosthesis mismatch (PPM) and assessment of THV function. Currently published reference EOAs, however, are based on transthoracic echocardiography (TTE), which may be subject to left ventricular outflow tract diameter underestimation and/or suboptimal THV Doppler interrogation. The objective of this study was to establish reference EOA values for BE THVs on the basis of Doppler and three-dimensional (3D) transesophageal echocardiography (TEE). METHODS: Two hundred twelve intraprocedural transesophageal echocardiographic examinations performed during BE THV implantation with optimal postimplantation Doppler and 3D imaging were retrospectively reviewed. Continuity equation-derived EOAs were compared with geometric orifice areas by 3D planimetry (GOA3D). Performance indices (i.e., EOA normalized to valve size) and PPM rates were determined. TTE-based EOAs obtained within 30 days were also calculated in a subset of 170 patients. RESULTS: The average EOA for all BE THV valves (77% SAPIEN 3) was 2.3 ± 0.5 cm2, while the average EOA was 1.6 ± 0.2 cm2 for 20-mm, 2.0 ± 0.2 cm2, for 23-mm, 2.5 ± 0.3 cm2 for 26-mm, and 3.0 ± 0.3 cm2 for 29-mm THV size (P < .001). Bland-Altman analysis demonstrated very good agreement between EOA and GOA3D (bias -0.04 ± 0.15 cm2). There were strong correlations between annular area and TEE-based EOA (R = 0.84) and GOA3D (R = 0.87). The mean performance index was 47 ± 5% and was similar for all THV sizes (P = .21). EOAs based on TTE were smaller compared with those based on TEE, while the correlation with annular area (R = 0.67) and agreement with GOA3D (bias -0.26 ± 0.43 cm2) was not as strong. The overall PPM rate was 2% in the TEE cohort and 12% in the TTE cohort. CONCLUSIONS: EOAs for BE THVs based on intraprocedural Doppler and 3D TEE suggest that previously published TTE-based reference values for EOA are underestimated, while PPM rates may be overestimated. Our findings have important clinical implications for preimplantation decision-making and for the evaluation of THV hemodynamics and function during follow-up.


Asunto(s)
Estenosis de la Válvula Aórtica , Prótesis Valvulares Cardíacas , Reemplazo de la Válvula Aórtica Transcatéter , Válvula Aórtica/diagnóstico por imagen , Ecocardiografía , Ecocardiografía Transesofágica , Humanos , Diseño de Prótesis , Estudios Retrospectivos , Resultado del Tratamiento
5.
J Clin Med ; 9(12)2020 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-33271929

RESUMEN

Treatment of giant cell myocarditis (GCM) can require bridging to orthotopic heart transplantation (OHT) or recovery with mechanical circulatory support (MCS). Since the roles of MCS and immunotherapy are not well-defined in GCM, we sought to analyze outcomes of patients with GCM who required MCS. A systematic search was performed in June 2019 to identify all studies of biopsy-proven GCM requiring MCS after 2009. We identified 27 studies with 43 patients. Patient-level data were extracted for analysis. Median patient age was 45 (interquartile range (IQR): 32-57) years. 42.1% (16/38) were female. 34.9% (15/43) presented in acute heart failure. 20.9% (9/43) presented in cardiogenic shock. Biventricular (BiVAD) MCS was required in 76.7% (33/43) of cases. Of the 62.8% (27/43) of patients who received immunotherapy, 81.5% (22/27) used steroids combined with at least one other immunosuppressant. Cyclosporine was the most common non-steroidal agent, used in 40.7% (11/27) of regimens. Immunosuppression was initiated before MCS in 59.3% (16/27) of cases, after MCS in 29.6% (8/27), and not specified in 11.1% (3/27). Immunosuppression started prior to MCS was associated with significantly better survival than MCS alone (p = 0.006); 60.5% (26/43) of patients received bridge-to-transplant MCS; 39.5% (17/43) received bridge-to-recovery MCS; 58.5% (24/41) underwent OHT a median of 104 (58-255) days from diagnosis. GCM recurrence after OHT was reported in 8.3% (2/24) of transplanted cases. BiVAD predominates in mechanically supported patients with GCM. Survival and bridge to recovery appear better in patients on immunosuppression, especially if initiated before MCS.

7.
Heart Surg Forum ; 10(1): E78-80, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17311770

RESUMEN

Percutaneous stenting of the superior vena cava (SVC) has been an accepted therapy for SVC syndrome for more than a decade. Complications are uncommon and usually of minor consequence. Three previous reports have described ruptures of the SVC during venoplasty with death on one occasion. We report a fourth case of SVC rupture during angioplasty and stenting that required immediate pericardiocentesis followed by open surgical repair via sternotomy for direct control and repair. An algorithm for rapid recognition and prompt intervention is described.


Asunto(s)
Angioplastia de Balón/efectos adversos , Prótesis Vascular/efectos adversos , Lesiones Cardíacas/etiología , Lesiones Cardíacas/cirugía , Stents/efectos adversos , Síndrome de la Vena Cava Superior/cirugía , Vena Cava Superior/cirugía , Adulto , Femenino , Lesiones Cardíacas/diagnóstico , Humanos , Síndrome de la Vena Cava Superior/complicaciones , Vena Cava Superior/lesiones
8.
ASAIO J ; 63(3): 273-278, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-27861427

RESUMEN

Insertion of a left ventricular assist device (LVAD) improves survival and quality of life (QOL) in patients with class IV heart failure failing medical management. However, QOL and survival of patients bridged to LVAD with extracorporeal membrane oxygenation (ECMO) is unknown. Between July 2008 and June 2014, 213 patients underwent insertion of HeartMate II LVAD at two VAD centers without a bridge with a temporary VAD. Extracorporeal membrane oxygenation was used as a bridge before LVAD insertion in 22 Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 1 patients (ECMO-VAD group). No bridge was used in 21 INTERMACS 1 patients and 170 INTERMACS 2-4 patients (primary LVAD group). Survival was compared between the ECMO-VAD group and INTERMACS 1 patients who underwent a primary LVAD insertion (INTERMACS 1 group). Quality of life was compared between the ECMO-VAD group and the primary LVAD group as a whole. The in-hospital mortality of the ECMO-VAD and INTERMACS1 groups was 23% and 14%, respectively (P = 0.38). The postimplant QOL scores of the ECMO-VAD group were not different compared with the primary LVAD group. Although the ECMO-VAD group consists of critically ill patients, the QOL and survival after discharge were not significantly different compared with patients who were not bridged with ECMO.


Asunto(s)
Oxigenación por Membrana Extracorpórea , Insuficiencia Cardíaca/terapia , Corazón Auxiliar , Calidad de Vida , Adulto , Oxigenación por Membrana Extracorpórea/instrumentación , Femenino , Insuficiencia Cardíaca/psicología , Mortalidad Hospitalaria , Humanos , Masculino , Persona de Mediana Edad
11.
Ann Thorac Surg ; 101(5): 1729-34, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-26872734

RESUMEN

BACKGROUND: There are various factors that can influence the survival of patients receiving venoarterial extracorporeal membrane oxygenation (VA ECMO). Vascular complications from femoral cannulation are common and are potentially serious. We analyzed the impact of vascular complications on survival of patients receiving VA ECMO. METHODS: Patients supported with VA ECMO by means of femoral cannulation from October 2010 to November 2014 were enrolled in this study. Data were gathered retrospectively by reviewing our institutional database. Patients were separated into two groups depending on the presence of major vascular complications, defined as patients who required surgical intervention. We evaluated predisposing factors for vascular complications and compared survival of patients in each group. RESULTS: There were 84 patients enrolled in the study. The rates of overall ECMO survival and survival to hospital discharge were 60% and 43%, respectively. Major vascular complications requiring surgical intervention were seen in 17 (20%) patients. Ten patients (12%) had compartment syndrome requiring prophylactic fasciotomy, and 10 patients (12%) had bleeding or hematoma requiring surgical exploration. The only significant predisposing factor for vascular complications was the absence of a distal perfusion catheter (odds ratio, 14.8; p = 0.03). The rate of survival to discharge was 18% and 49% in patients with and without vascular complications, respectively (p = 0.02). Vascular complications were an independent factor of significantly worse survival in patients receiving VA ECMO by multivariate analysis (hazard ratio, 2.17; p = 0.02). CONCLUSIONS: Vascular complications negatively affect survival in patients receiving VA ECMO support by means of femoral cannulation. The utilization of a distal perfusion catheter can decrease the incidence of complications.


Asunto(s)
Cateterismo Periférico/efectos adversos , Oxigenación por Membrana Extracorpórea/mortalidad , Adulto , Anciano , Oxigenación por Membrana Extracorpórea/efectos adversos , Femenino , Arteria Femoral , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
14.
Heart Lung ; 44(3): 225-9, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25746483

RESUMEN

OBJECTIVES: To determine if driveline infection is related to dressing change frequency in hospitalized adult patients with newly implanted left ventricular assist devices (LVAD). BACKGROUND: Guidelines do not exist for the frequency of driveline exit-site dressing change in hospitalized patients resulting in wide variation in practice. METHODS: A retrospective chart review was conducted on 68 patients implanted with a HeartMate II LVAD between August 2008 and September 2013 at an urban medical center. RESULTS: No driveline infections were found. Frequency of the driveline dressing change varied from daily, three times a week, and weekly. The daily dressing change group was younger in age compared to the weekly group (p = 0.005) and three times a week group (p = 0.001). No other differences were found. CONCLUSION: Driveline infections do not appear to be related to the frequency of dressing change in this population. Our data and other studies on this topic thus far are too limited to draw definitive conclusions about optimal frequency of dressing change for infection prevention.


Asunto(s)
Vendajes , Corazón Auxiliar/efectos adversos , Infecciones Relacionadas con Prótesis/prevención & control , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Infecciones Relacionadas con Prótesis/epidemiología , Estudios Retrospectivos
18.
J Thorac Cardiovasc Surg ; 126(1): 124-32, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12878947

RESUMEN

BACKGROUND: Intercellular crosstalk and cellular plasticity are key factors in embryogenesis and organogenesis. The microenvironment plays a critical role in directing the progression of stem cells into differentiated cells. We hypothesized that intercellular interaction between adult human mesenchymal stem cells and adult human cardiomyocytes would induce stem cells to acquire the phenotypical characteristics of cardiomyocytes, and we tested the role that direct cell-to-cell contact plays in directing this differentiation process. Human mesenchymal stem cells were cultured in the presence of human cardiomyocytes ("coculture") or in the presence of media conditioned by separate cultures of human cardiomyocytes ("conditioned media"). METHODS: Human cardiomyocytes were labeled with chloromethyl derivatives of fluorescein diacetate. In the coculture experiments, human mesenchymal stem cells and human cardiomyocytes were mixed at a 1:1 ratio in smooth muscle 2 media and seeded at a cell density of 10,000 cells/cm(2). Cells were cocultured in an incubator at 37 degrees C for 48 hours. Subsequently, fluorescence-activated cell sorting was used to extract the differentiating human mesenchymal stem cells. In the conditioned media experiments, human mesenchymal stem cells were incubated in media previously conditioned by cardiomyocytes, in the presence and absence of serum (+/-serum). The conditioned media was changed 3 times, at intervals of 48 hours. Total RNA was isolated and reverse transcriptase-polymerase chain reaction was performed for expression of contractile proteins and cardiac specific genes. Immunostaining against myosin heavy chain, beta-actin troponin-T, and troponin-I was performed. RESULTS: Fluorescence-activated cell sorting analysis identified 66% of the human mesenchymal stem cells in the G1 phase. Differentiated hMSCs from the coculture experiments expressed myosin heavy chain, beta-actin, and troponin-T by reverse transcriptase-polymerase chain reaction. Immunostaining was also positive against myosin heavy chain and troponin-T. In contrast, only beta-actin expression was observed in the human mesenchymal stem cells incubated with conditioned media +/- serum. CONCLUSION: In addition to soluble signaling molecules, direct cell-to-cell contact is obligatory in relaying the external cues of the microenvironment controlling the differentiation of adult stem cells to cardiomyocytes. These data indicate that human mesenchymal stem cells are plastic and can be reprogrammed into a cardiomyogenic lineage that may be used in cell-based therapy for treating heart failure.


Asunto(s)
Mesodermo/citología , Mesodermo/metabolismo , Miocitos Cardíacos/fisiología , Fenotipo , Células Madre/fisiología , Actinas/genética , Actinas/metabolismo , Adulto , Comunicación Celular/fisiología , Diferenciación Celular/fisiología , Células Cultivadas , Ligamiento Genético/genética , Humanos , Inmunohistoquímica , Mitosis/fisiología , Miocitos Cardíacos/metabolismo , Cadenas Pesadas de Miosina/genética , Cadenas Pesadas de Miosina/metabolismo , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Transducción de Señal/genética , Células Madre/metabolismo , Troponina I/genética , Troponina I/metabolismo , Troponina T/genética , Troponina T/metabolismo
19.
Ann Thorac Surg ; 73(3): 1009-15, 2002 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11899954

RESUMEN

The frequency of esophageal carcinoma continues to increase in North America primarily because of the increased incidence of Barrett's epithelium in the distal esophagus and its malignant potential. Aggressive treatments involving multimodality therapies have been offered to improve overall poor survival rates. A review of this experience follows, to explain the rationale and to compare results of therapies. Although preoperative chemoradiation therapy is commonly used for locally advanced disease, few data support its superiority over surgical resection alone, followed by adjuvant therapy when appropriate. Hence this regimen should be limited to patients enrolled in controlled, randomized studies until the data support its widespread use.


Asunto(s)
Adenocarcinoma/cirugía , Carcinoma de Células Escamosas/cirugía , Neoplasias Esofágicas/cirugía , Antineoplásicos/uso terapéutico , Quimioterapia Adyuvante , Neoplasias Esofágicas/diagnóstico , Neoplasias Esofágicas/patología , Esofagoscopía , Humanos , Estadificación de Neoplasias , Valor Predictivo de las Pruebas , Radioterapia Adyuvante , Ensayos Clínicos Controlados Aleatorios como Asunto
20.
Cardiol Clin ; 21(1): 75-82, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12793412

RESUMEN

Myocardial recovery after VAD support provides a perfect example of reverse remodeling. It also establishes that heart failure may not be an end of the road situation. Although post-LVAD myocardial recovery has become a distinct entity, basis of reversal of the dedifferentiation process will need to be further explored. With this objective, several centers in the United States have formed the LVAD Working Group to: determine the incidence of myocardial recovery; obtain serial studies to determine the response of the LVAD-supported heart to stress; and study the tissue and serological changes as they relate to the recovery process. Patients enrolled in this study will receive anti-heart failure therapy and serial examinations after implantation and explanation. Stress evaluations will include dobutamine stress echocardiograms as well as bicycle exercise with right heart catheterization. A large database of prospectively collected data will likely result in a greater understanding of myocardial recovery and the LVAD weaning process.


Asunto(s)
Corazón Auxiliar , Corazón/fisiopatología , Recuperación de la Función/fisiología , Función Ventricular/fisiología , Humanos , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA